Parnassus Investments, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Parnassus Investments, LLC

  • $45.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 01, 2020
SELL
$336.18 - $494.43 $48.7 Million - $71.7 Million
-145,000 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $132 Million - $181 Million
-480,000 Reduced 76.8%
145,000 $54.4 Million
Q2 2019

Aug 08, 2019
BUY
$299.6 - $414.82 $139 Million - $193 Million
465,000 Added 290.63%
625,000 $196 Million
Q1 2019

May 01, 2019
BUY
$372.08 - $439.57 $59.5 Million - $70.3 Million
160,000 New
160,000 $65.7 Million

Others Institutions Holding REGN

# of Institutions
1,526
Shares Held
82.7M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Parnassus Investments, LLC Portfolio

Follow Parnassus Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parnassus Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email